It’s not often that an abandoned study garners national headlines—much less a study so riddled with methodological flaws that the researchers behind it admit to its inadequacy on the opening page of their article.
Yet, such is the case with a clinical trial conducted by Dr. Mitchell D. Creinin of UC Davis.
In conjunction with a Planned Parenthood affiliate and a local abortion clinic, Creinin set out to debunk a process known as “abortion pill reversal,” which is a cutting-edge application of a time-tested, FDA-approved drug used for decades to prevent miscarriage and pre-term birth.
Predictably, Creinin and his colleagues had to stop the trial amid
safety concerns when three of the 12 women enrolled in the study
experienced “severe hemorrhaging” after having started a chemical abortion.
Although Creinin asserts in the journal Contraception (behind a paywall) that his cohort’s study shows the dangers of abortion pill reversal, the study itself doesn’t show that at all. In fact, the study’s incomplete findings actually serve to underscore the hazards of mifepristone—the first pill in the abortion pill regimen.
Read more at Pregnancy Help News